Vascular prothesis having flexible configuration

• US 20050033410A1
• Filed: 08/04/2004
• Published: 02/10/2005
• Est. Priority Date: 12/24/2002
• Status: Abandoned Application

• Current Assignee: NovoStent Corp.
• Original Assignee: NovoStent Corp.
• Inventors: Hogendijk, Michael, Leopold, Eric, Alexander, Miles
• Application Number:
  US10/911,435
• Publication Number:
  US 20050033410A1
• Time in Patent Office: Days
• US Class Current: 623/1.150
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/88 the wire-like elements formed as helical or spiral coils forming a net-like or mesh-like structure A61F2/90
• CPC Class Codes: A61F 2/89 the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
• CPC Class Codes: A61F 2/90 characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2/95 Instruments specially adapted for placement or removal of stents or stent-grafts
• CPC Class Codes: A61F 2/958 Inflatable balloons for placing stents or stent-grafts
• CPC Class Codes: A61F 2/966 with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
• CPC Class Codes: A61F 2002/072 Encapsulated stents, e.g. wire or whole stent embedded in lining
• CPC Class Codes: A61F 2002/826 more than one stent being applied sequentially
• CPC Class Codes: A61F 2002/828 Means for connecting a plurality of stents allowing flexibility of the whole structure
• CPC Class Codes: A61F 2002/91525 within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
• CPC Class Codes: A61F 2002/91533 characterised by the phase between adjacent bands
• CPC Class Codes: A61F 2002/91558 connected peak to peak
• CPC Class Codes: A61F 2230/0054 V-shaped
• CPC Class Codes: A61F 2250/0068 the pharmaceutical product being in a reservoir

Abstract

An implantable vascular prosthesis having improved flexibility is provided comprising a helical body portion having a reduced delivery configuration and an expanded deployed configuration, the helical body portion comprising a plurality of cells interconnected by hinge points that enhances flexibility of the vascular prosthesis in the reduced delivery configuration.

Claims

1. An implantable vascular prosthesis having improved flexibility, comprising:

a helical body portion having a length, a reduced delivery configuration and an expanded deployed configuration, the helical body portion comprising a plurality of cells aligned helically along the length of the helical body portion to enhance flexibility of the vascular prosthesis in the reduced delivery configuration.

2. The vascular prosthesis of claim 1, wherein the plurality of cells comprises one or more substantially parallel struts.

3. The vascular prosthesis of claim 1, wherein the plurality of cells is interconnected by hinges and the cells are aligned substantially end-to-end along the length of the helical body portion.

4. The vascular prosthesis of claim 3, wherein the plurality of cells are diamond-shaped, triangular, rhomboidal, or pentagonal.

5. The vascular prosthesis of claim 3, wherein each cell includes a plurality of corners and the hinges are disposed at the corners to allow shape changes to occur in a planar fashion.

6. The vascular prosthesis of claim 1, wherein plurality of cells is arranged in rows that are staggered relative to a longitudinal axis of the vascular prosthesis.

7. The vascular prosthesis of claim 1, wherein a radial force of the vascular prosthesis is controlled by varying placement of the hinges.

8. The vascular prosthesis of claim 6, wherein a radial force of the vascular prosthesis is controlled by varying an angle at which adjacent rows are staggered.

9. The vascular prosthesis of claim 1, wherein the plurality of cells is configured to reduce interengagement of turns of the helical body portion in the reduced delivery configuration.

10. The vascular prosthesis of claim 9, wherein the cells are elongated along the length of the helical body portion.

11. The vascular prosthesis of claim 1, wherein the hinges of adjacent rows of cells are aligned at an angle with respect to a longitudinal axis of the vascular prosthesis.

12. The vascular prosthesis of claim 11, wherein a radial force of the body portion is controlled by varying the angle at which the hinges of adjacent rows of cells are aligned.

13. The vascular prosthesis of claim 1, wherein the helical body portion has a reduced diameter circumference representing a circumference of the helical body portion in the reduced delivery configuration.

14. The vascular prosthesis of claim 13, wherein each cell of the plurality of cells is sized so that cell length is an integral fraction of the reduced diameter circumference.

15. The vascular prosthesis of claim 14, wherein each cell of the plurality of cells is sized so that cell length is an integral number of cells per reduced diameter circumference.

16. The vascular prosthesis of claim 1 wherein the helical body portion has a distal end, the vascular prosthesis further comprising a radially self-expanding tubular anchor coupled to the distal end of the helical body portion.

17. The vascular prosthesis of claim 1 further comprising a coating that elutes a bioactive substance.

18. A stent comprising a helical portion having a length, a delivery configuration and a deployed configuration, the helical portion comprising a plurality of cells aligned end-to-end helically along the length of the helical portion.

19. The stent of claim 18, wherein the plurality of cells is interconnected by hinges that are aligned along the helix of the helical portion.

20. The stent of claim 18, wherein the plurality of cells are diamond-shaped, triangular, rhomboidal or pentagonal.

21. The stent of claim 18, wherein each cell includes a plurality of corners and the hinges are disposed at the corners to allow shape changes to occur in a planar fashion.

22. The stent of claim 18, wherein plurality of cells is arranged in rows that are staggered relative to a longitudinal axis of the vascular prosthesis.

23. The stent of claim 18, wherein the plurality of cells is configured to reduce interengagement of turns of the helical portion in the delivery configuration.

24. The stent of claim 18, wherein the cells are elongated along the length of the helical body portion.

25. The stent of claim 18, wherein the hinges of adjacent rows of cells are aligned at an angle with respect to a longitudinal axis of the vascular prosthesis.

26. The stent of claim 18, wherein the helical portion has a reduced diameter circumference representing a circumference of the helical portion in the delivery configuration, each cell of the plurality of cells sized so that cell length is an integral fraction of the reduced diameter circumference.

27. The stent of claim 18 wherein the helical portion has a distal end, the stent further comprising a radially self-expanding tubular anchor coupled to the distal end of the helical portion.

28. The vascular prosthesis of claim 18 further comprising a coating that elutes a bioactive substance.